These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31342537)

  • 1. Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD.
    van Gennep S; Konté K; Meijer B; Heymans MW; D'Haens GR; Löwenberg M; de Boer NKH
    Aliment Pharmacol Ther; 2019 Sep; 50(5):484-506. PubMed ID: 31342537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy.
    Bayoumy AB; Ansari AR; Mulder CJJ; Schmiegelow K; Florin T; De Boer NKH
    Clin Pharmacokinet; 2024 Aug; 63(8):1089-1109. PubMed ID: 39031224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjustment of azathioprine dose should be based on a lower 6-TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers.
    Kang B; Kim TJ; Choi J; Baek SY; Ahn S; Choi R; Lee SY; Choe YH
    Aliment Pharmacol Ther; 2020 Aug; 52(3):459-470. PubMed ID: 32598049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.
    Asada A; Nishida A; Shioya M; Imaeda H; Inatomi O; Bamba S; Kito K; Sugimoto M; Andoh A
    J Gastroenterol; 2016 Jan; 51(1):22-9. PubMed ID: 26590936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
    Kakuta Y; Kawai Y; Okamoto D; Takagawa T; Ikeya K; Sakuraba H; Nishida A; Nakagawa S; Miura M; Toyonaga T; Onodera K; Shinozaki M; Ishiguro Y; Mizuno S; Takahara M; Yanai S; Hokari R; Nakagawa T; Araki H; Motoya S; Naito T; Moroi R; Shiga H; Endo K; Kobayashi T; Naganuma M; Hiraoka S; Matsumoto T; Nakamura S; Nakase H; Hisamatsu T; Sasaki M; Hanai H; Andoh A; Nagasaki M; Kinouchi Y; Shimosegawa T; Masamune A; Suzuki Y;
    J Gastroenterol; 2018 Sep; 53(9):1065-1078. PubMed ID: 29923122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease.
    Wong DR; Coenen MJ; Vermeulen SH; Derijks LJ; van Marrewijk CJ; Klungel OH; Scheffer H; Franke B; Guchelaar HJ; de Jong DJ; Engels LG; Verbeek AL; Hooymans PM;
    J Crohns Colitis; 2017 Feb; 11(2):175-184. PubMed ID: 27402913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
    Kakuta Y; Naito T; Onodera M; Kuroha M; Kimura T; Shiga H; Endo K; Negoro K; Kinouchi Y; Shimosegawa T
    Pharmacogenomics J; 2016 Jun; 16(3):280-5. PubMed ID: 26076924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Chao K; Wang X; Cao Q; Qian J; Wu K; Zhu X; Yang H; Liang J; Lin L; Huang Z; Zhang Y; Huang Y; Sun Y; Xue X; Huang M; Hu P; Lan P; Gao X
    Inflamm Bowel Dis; 2017 Sep; 23(9):1592-1599. PubMed ID: 28570428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
    Akiyama S; Matsuoka K; Fukuda K; Hamada S; Shimizu M; Nanki K; Mizuno S; Kiyohara H; Arai M; Sugimoto S; Iwao Y; Ogata H; Hisamatsu T; Naganuma M; Motobayashi M; Suzuki K; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Mochizuki M; Watanabe M; Hashiguchi M; Kanai T
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1751-1757. PubMed ID: 31045285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn's disease patients.
    Zhu X; Chao K; Li M; Xie W; Zheng H; Zhang JX; Hu PJ; Huang M; Gao X; Wang XD
    World J Gastroenterol; 2019 Oct; 25(38):5850-5861. PubMed ID: 31636477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
    Ooi CY; Bohane TD; Lee D; Naidoo D; Day AS
    Aliment Pharmacol Ther; 2007 Apr; 25(8):941-7. PubMed ID: 17402998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A coding variant in
    Kim HS; Cheon JH; Jung ES; Park J; Aum S; Park SJ; Eun S; Lee J; Rüther U; Yeo GSH; Ma M; Park KS; Naito T; Kakuta Y; Lee JH; Kim WH; Lee MG
    Gut; 2017 Nov; 66(11):1926-1935. PubMed ID: 27558924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.
    Fangbin Z; Xiang G; Liang D; Hui L; Xueding W; Baili C; Huichang B; Yinglian X; Peng C; Lizi Z; Yanjun C; Feng X; Minhu C; Min H; Pinjin H
    Medicine (Baltimore); 2016 Apr; 95(15):e3326. PubMed ID: 27082580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
    Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T
    PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Yu N; Sriranganathan D; Walker GJ; Sazonovs A; Wilding H; Roberts C; Kennedy NA; Ahmad T; Boyapati RK; Ding NS; Segal JP
    J Crohns Colitis; 2023 Dec; 17(12):1920-1930. PubMed ID: 37346013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
    Armstrong L; Sharif JA; Galloway P; McGrogan P; Bishop J; Russell RK
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.
    Dubinsky MC; Lamothe S; Yang HY; Targan SR; Sinnett D; Théorêt Y; Seidman EG
    Gastroenterology; 2000 Apr; 118(4):705-13. PubMed ID: 10734022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis.
    Cargnin S; Genazzani AA; Canonico PL; Terrazzino S
    Pharmacol Res; 2018 Sep; 135():102-111. PubMed ID: 30048756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.